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Summary sentence: beta cell communication during type 2 diabetes 1 
 2 
Pubmed was searched using combinations of the following: “islet”, “diabetes”, “electrical”, 3 
“activity”, “channels”, “calcium”, “sodium”, “potassium”, “incretin”, “GLP-1”, “GIP”, 4 
“coordination”, “synchrony”, “dynamics”, “gap junction”, “connexin 36”, “paracrine”, “architecture”, 5 
“structure”, “autocrine”, “genetics”, “neural”, “tcf7l2”, “adcy5” and “gipr”. 6 
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Abstract 1 
Beta cell connectivity describes the phenomenom whereby the islet context improves insulin 2 
secretion by providing a three-dimensional platform for intercellular signaling processes. Thus, 3 
the precise flow of information through homotypically interconnected beta cells leads to the 4 
large-scale organization of hormone-release activities, influencing cell responses to glucose and 5 
other secretagogues. Although a phenonemon whose importance has arguably been under-6 
appreciated in islet biology until recently, a growing number of studies suggest that such cell-cell 7 
communication is a fundamental property of this micro-organ. Hence, connectivity may plausibly 8 
be targeted by both environmental and genetic factors in type 2 diabetes mellitus (T2DM) to 9 
perturb normal beta cell function and insulin release. Here, we review the mechanisms that 10 
contribute to beta cell connectivity, discuss how these may fail during T2DM, and examine 11 
approaches to restore insulin secretion by boosting cell communication.  12 
 13 
 14 
 15 
 16 
Abbreviations: AC, adenyl cyclase; ACh, acetyl-choline; ADP, adenosine diphosphate; ATP, 17 
adenosine triphosphate; cAMP, cyclic adenosine monophosphate; Cx36, connexin 36; Epac, 18 
exchange protein activated by cAMP; fMCI, functional multicellular calcium imaging; GABA, 19 
gamma aminobutyric acid; GIP, glucose-dependent insulinotropic polypeptide; GJ, gap junction; 20 
GLP-1, glucagon-like peptide-1; GWAS, genome-wide association studies; GPCR, G-protein 21 
coupled receptor; KATP, ATP-sensitive K+ channel; SST, somatostatin; SNP, single nucleotide 22 
polymorphism; T2DM, Type 2 diabetes mellitus; VDCC, voltage-dependent Ca2+-channel.  23 
 3 
Introduction 1 
Type 2 diabetes mellitus (T2DM) is a global epidemic that currently consumes ~10% of the 2 
healthcare budget in the developed world [1]. This syndrome has a complex aetiology but can be 3 
summarised as a failure of the beta cell mass to adequately compensate for insulin resistance, or 4 
alternatively a primary beta cell defect that leads to insulin resistance. The resulting glucose 5 
intolerance, coupled with dyslipidemia, drives a range of costly secondary complications 6 
including retinopathy, vasculopathy, renal failure, cancer and cardiovascular disease [2,3]. 7 
Consequently, elucidation of the mechanisms underlying the control of insulin secretion from 8 
individual beta cells has been the focus of intense research efforts. Thus, in response to an 9 
elevation of blood glucose, equilibration of the sugar across the plasma membrane occurs rapidly 10 
and is achieved via either the low affinity glucose transporter Glut2/slc2a2 (rodents) or the higher 11 
affinity transporter Glut1/slc2a1 (man) [4]. The low affinity hexokinase, glucokinase is then 12 
chiefly responsible for determining glycolytic flux towards pyruvate [5]. Conversion of the latter 13 
to acetyl-CoA in the mitochondrial matrix, and its oxidation via the tricarboxylate cycle, then 14 
ensues [6,7]. The resultant increases in the ratio of free ATP to ADP (ATP:ADP) in the cytosol 15 
[8] and sub-plasma membrane domain [9] then leads to closure of ATP-sensitive K+ channels 16 
(KATP), membrane depolarisation and the influx of calcium (Ca2+) through voltage-dependent 17 
Ca2+-channels (VDCC) [6,7,10,11]. Together with the activation of a less well-defined 18 
“amplifying” pathway [12,13], localized increases in the intracellular free Ca2+ concentration 19 
[14], including at the surface of the secretory granule [15], then provoke insulin release through 20 
interactions with the exocytotic machinery [16,17].  21 
  22 
By comparison, the population-level regulation of insulin release is less well understood, 23 
although the idea that it may contribute to T2DM risk has been suggested [18-22]. Providing 24 
evidence that cell-cell interactions are a prerequisite for proper hormone secretion is the 25 
observation that beta cells incommunicado (i.e. as isolated cells) release less insulin per capita 26 
than their properly-connected counterparts within the intact islet [19,23,24]. Indeed, a feature of 27 
the endocrine pancreas is the three-dimensional encapsulation of beta, and other cell types, into 28 
islets of Langerhans, a biological scaffold for cell-cell communications. Since these microorgans 29 
are conserved throughout the mammalian kingdom and beyond [25], albeit with important 30 
differences in the numbers of each cell type and their arrangement within the islet (see below), 31 
the intraislet mechanisms governing insulin secretion may represent an underappreciated target 32 
through which T2DM insults provoke hyperglycemia. Building upon recent findings from our 33 
own [26-28] and others’ [20-22,29-31] laboratories, the aim of the present review is to describe 34 
our current understanding as to how beta cell-beta cell communication (hereafter referred to as 35 
 4 
“connectivity”) contributes to the normal regulation of insulin secretion in healthy subjects. We 1 
also discuss how changes in this property may contribute to T2DM risk in genetically-susceptible 2 
individuals.  3 
 4 
Islets as discrete secretory units 5 
The term “endocrine pancreas” describes the thousands (millions in man) of islets of Langerhans 6 
scattered throughout the exocrine tissue. Each islet can range in size from 20-400 µM and 7 
comprises alpha- (glucagon), beta- (insulin), delta- (somatostatin), epsilon- (ghrelin) and 8 
pancreatic polypeptide (PP) cells. Strikingly, islets are evolutionarily-stable structures and are 9 
present in most mammals studied to date, including the Beluga whale, with a similar range of 10 
sizes reported in each species [25]. With the exception of bats, horses, hyenas, primates and 11 
humans, the arrangement of endocrine cells within islets is similar [25]. Thus, in rodent islets, the 12 
most-studied model, beta cells form a central core, with alpha cells occupying the mantle 13 
[25,32,33]. Suggesting that this may be a consequence of the vasculature, blood flow has been 14 
shown to follow an inner-outer flow pattern, irrigating beta before alpha cells in this species [34], 15 
and the vasculature appears to be instructive for pancreas development [35]. By contrast, beta 16 
cells in human islets are interspersed with alpha cells, in part the consequence of the tertiary 17 
folding of an initial trilaminar alpha-beta-alpha sheet, which promotes heterologous contacts 18 
[33,36-38]. As well as differences in islet architecture, alterations to cell proportion are also 19 
apparent between species. For example, the ratio of beta:alpha cells in rodent islets is ~4:1, 20 
whereas in humans it is ~1.25:1. Such divergence in islet architecture likely influences cell-cell 21 
communication by altering the extent and nature of cell-cell signaling processes, and may be an 22 
important source of species differences in islet function. Regardless, the islet structure is  23 
permissive for insulin secretion, and beta cells in two dimensions display blunted responses to 24 
input, both in terms of Ca2+ signaling and magnitude hormone release [27,39-41]. 25 
 26 
High-speed imaging of beta cell connectivity 27 
Over the last decade, advances in microscopy have allowed cell dynamics to be monitored in situ 28 
within the intact tissue setting [42]. Key to this is the use of high-speed imaging, which when 29 
combined with highly-sensitive detectors, allows a large area to be rapidly traversed at cellular 30 
resolution. In terms of endocrine organ function, the physiologically relevant output is hormone 31 
release. However, large-scale imaging of exocytosis in individual cells is only just becoming 32 
possible, although the currently available dyes possess signal-to-noise ratios incompatible with 33 
high-speed acquisition at visible light wavelengths [43-46]. To circumvent these issues, 34 
membrane voltage or intracellular Ca2+ concentrations can instead be used as a proxy for Ca2+-35 
 5 
dependent hormone release [47-50]. To this end, functional multicellular Ca2+ imaging (fMCI), 1 
originally used to map activity in cortical circuits [51-53], has recently been adapted for use in 2 
beta cells [27,28]. By coupling a laser bank to a Nipkow spinning disk, the millisecond 3 
organization of beta cell population Ca2+-spiking activity can be captured in near real-time with 4 
reduced phototoxicity and photobleaching. Following acquisition, the datasets are subjected to 5 
non-deterministic Monte Carlo-based models to identify the cells with similar behavioural 6 
profiles, i.e. those with correlated activity and which are assumed to contribute to the same 7 
secretory process [42,54]. Statistical significance is determined by shuffling the experimental 8 
dataset and calculating the likelihood of detecting the same correlation pattern due to chance. A 9 
functional connectivity map can then be constructed based on the location of significantly 10 
correlated cells pairs, allowing perturbations to beta cell connectivity to be evaluated (see Figure 11 
1, top panel, for an example). In a refinement of this method, beta cell metabolic interconnectivity 12 
has recently been mapped in intact islets by monitoring intracellular free ATP:ADP dynamics, as 13 
for Ca2+ [55]. When using these techniques, it is important to note that the territories of 14 
communicating beta cells within intact islets are larger than those that can be recorded, limiting 15 
any physiological inferences that can be drawn.  16 
 17 
Islet wiring patterns  18 
Network science principally relies on the use of graph theory to identify the interactions that 19 
govern behavior in complex systems (see [42] for a review of network science in Endocrinology). 20 
Using these approaches, it has become increasingly clear that network topology tends to be 21 
conserved (e.g. scale-free and random) irrespective of the components examined (e.g. cells versus 22 
people) [42,56,57]. Recent research has shown that graph theory is also applicable to the 23 
description of complex dynamics in the endocrine pancreas. Thus, analysis reveals that beta cells 24 
comprise glucose-responsive scale-free networks in which cells can communicate over long 25 
distances, through presently undefined mechanisms [29]. Such network topologies are defined by 26 
a power-law distributed link probability in which a minority of cells (termed highly-connected 27 
nodes) host the majority of connections and are said to possess small-world properties if there is a 28 
tendency towards formation of cliques (six degrees of separation concept) (Figure 1, bottom 29 
panel). Price was the first to describe scale-free networks, noting that journal citations follow a 30 
power-law distribution, sharing features in-keeping with Pareto’s law (the ‘rich-get-richer’ 31 
hypothesis) [58]. Subsequently, Barabasi and Albert showed that preferential attachment is 32 
responsible for the emergence of scale-free properties [59]. Notably, scale-free distributions are 33 
ubiquitous and have been described in social networks, computer networks, neural networks and 34 
anterior pituitary networks [54,60-63]. An important feature of scale-free networks is robustness 35 
 6 
at low wiring cost: the chances of a random attack disabling communication are low and the use 1 
of hubs to route information reduces signal transmission length [42]. However, should the highly-2 
connected nodes be specifically targeted, the network is vulnerable to collapse, since a high 3 
proportion of links will be lost (Figure 1, bottom panel). Therefore, an interesting but untested 4 
possibility is that highly-connected beta cell nodes may represent a subpopulation which is 5 
particularly susceptible to T2DM insults. Conversely, these highly-connected nodes may serve as 6 
a functional reserve to maintain islet function in the face of gross perturbation by allowing the re-7 
distribution of information, again, a hypothesis that requires experimental validation. 8 
 9 
Mechanisms underlying beta cell-beta cell connectivity  10 
Neural circuits have a clear basis for long-range connectivity, since neurons send out axonal 11 
projections that can form synapses located millimetres apart. By contrast, it is less easy to 12 
conceptualize how beta cells within the islet can communicate over long distances to organize 13 
their activities. Might this involve, for example, “physical connections” (e.g. through islet inter-14 
neurons) between remote cells, or alternatively linearly-connected “trains” of beta or other cells 15 
along which signals are transmitted to a distant cell(s) from a controller (“pacemaker”) at a 16 
coordination hub? In any case, the islet possesses a formidable signaling toolbox (see Figure 2). 17 
This is reviewed in depth elsewhere [20,21,28,64], so here we limit our discussion to the 18 
pathways which may conceivably underlie connectivity between beta cells. 19 
 20 
Gap junctions: The best characterized cell-cell coupling mechanism in the pancreas is provided 21 
by gap junctions (GJ). Beta cells within rodent and human islets are homotypically-connected by 22 
connexin 36 (Cx36 or GJD2) [65,66]. GJs comprised of Cx36 are charge and size-selective 23 
channels that allow the intercellular passage of ions (e.g. Ca2+, Na+ and Zn2+) and nucleotides 24 
(e.g. ATP) [19,20,67]. Providing evidence that Cx36 is critical for coordinating islet activity are 25 
the observations that dispersed beta cells fail to synchronize their responses to glucose, and islets 26 
lacking Cx36 display more stochastic activity patterns due to increases in beta cell functional 27 
heterogeneity [31,68-70]. GJ-linkages are essential for the regulation of normal hormone release, 28 
since mice deleted for Cx36 are glucose intolerant and display impaired pulsatility, as well as 29 
elevated basal insulin secretion [22,68,71]. It is unclear how GJs could account for the long-range 30 
functional connections that project between distant cells, as practically all beta cells express Cx36 31 
protein, meaning that communication should encompass even close neighbors [65,72]. However, 32 
heterogeneity exists in fluorescence recovery after photobleaching (FRAP) within islets [73], 33 
suggesting that connectivity patterns between individual beta cells may at least reflect differences 34 
in functional GJ coupling. As proposed above, this may lead to the formation of linear groups of 35 
 7 
cells, tightly interconnected in three dimensions between one another, but (relatively) isolated 1 
from neighboring cells outside the train, thus forming a conduit for the passage of ionic (Ca2+) or 2 
other (e.g. paracrine, see below) signals. 3 
 4 
Neural: Islets receive rich innervation from the autonomic nervous system, and neural regulation 5 
of insulin secretion is critical for normal glucose homeostasis in vivo. The existence of a physical 6 
network of neurons to couple remote beta cells within the islet thus provides a conceptually 7 
straightforward model to explain recent experimental observations [26,27,29]. Indeed, insulin 8 
release is strongly stimulated by postganglionic cholinergic fibres that signal via acetycholine 9 
(ACh)-mediated activation of muscarinic receptors to phase-set and synchronize beta cell activity 10 
within and, potentially, between islets [74-76]. Such activation underpins the cephalic phase of 11 
insulin secretion in anticipation of food [77]. In addition, other neuropeptides including pituitary 12 
adenylate cyclase activating peptide (PACAP) and vasoactive intestinal peptide (VIP) may 13 
contribute to the parasympathetic control of beta cell function [74,78]. By contrast, insulin release 14 
is suppressed by noradrenergic sympathetic neurons that signal via α2-adrenoreceptors to open 15 
KATP channels [74,79,80], although a stimulatory effect of noradrenaline has also been observed, 16 
probably through effects on cAMP accumulation and β-adrenoreceptor activation [81,82]. 17 
Marked differences exist in the neural regulation of insulin secretion between rodents and man. 18 
Thus, human islets are relatively devoid of parasympathetic nerve fibres [83], and glucose-19 
sensitization of beta cell activity instead relies upon ACh release from vesicular acetylcholine 20 
transporter-expressing alpha cells [84,85]. This lack of direct innervation may partly explain why 21 
beta cell glucose responses in human islets are largely stochastic, with synchrony detected only 22 
between small cell clusters [27,33,86]. Conversely, the assessment of whether neurons contribute 23 
to long-range connectivity in mouse islets firstly requires confirmation of cholinergic fibre 24 
survival in isolated islets, followed by their specific manipulation (e.g. using patch clamp).  25 
 26 
Primary cilia: Cilia can be regarded as cell extensions that act as signaling hubs due to 27 
expression of G-protein coupled receptors, ion channels and transcription factors [87]. Primary 28 
cilia are immotile and are formed from a ring of nine microtubule doublets wrapped in a 29 
membrane sheath [88]. While studies of Kif3a, Lkb1 and Rfx3 knockout mice have all invoked a 30 
role for cilia in pancreatic development (i.e. ductal and endocrine cell specification) [87,89-91], 31 
little is known about their involvement in cell-cell signaling processes within the islet. Given the 32 
role of cilia in signal transmission in in other tissues [92], and potentially in exosome-mediated 33 
intercellular communications [93], we believe this warrants further investigation.  34 
 35 
 8 
Paracrine signaling:  1 
Intercellular communication may also be possible via the production and secretion of messengers 2 
which act on neighboring cells [20,21,28]. Over 230 secreted factors have been identified in 3 
rodent islets [94], and a number of signalling loops with roles in the regulation of beta cell 4 
function and insulin release are now well characterised (see references [21,28,64]). Despite this, it 5 
is unclear how paracrine factors could contribute to the complex functional islet wiring patterns 6 
described using graph theory [29,30], since all beta cells within the molecule diffusion path 7 
would be expected to be affected. Although it is plausible that active transport mechanisms and 8 
cognate receptor expression levels/patterns may allow more precise communication between beta 9 
cells, this needs further study. 10 
 11 
Despite the plethora of signaling mechanisms available within the islet, we suggest that a 12 
combination of modalities is required for producing the complex activity patterns that underlie 13 
beta cell-beta cell communication and connectivity. Notably, differences in signaling input, 14 
together with alterations to islet architecture, may play an important role in determining species-15 
specific responses to secretagogues such as glucose and incretins.  16 
 17 
Glucose and GLP-1-regulated connectivity: metabolic signals 18 
It is generally acknowledged that metabolic activity within individual beta cells is oscillatory, and 19 
that this generates the membrane bursting activity required for Ca2+ influx and exocytosis [95]. 20 
Whether metabolic oscillations are driven by Ca2+ oscillations, or vice versa, is still the source of 21 
debate [95,96], but the islet context seems to be critical, since dispersed beta cells display reduced 22 
periodicity in mitochondrial potential [97]. Moreover, total internal reflection fluorescence 23 
(TIRF) microscopy of mouse islets has shown that near-membrane glucose-induced oscillations 24 
in ATP:ADP are coordinated between small beta cell clusters [98], confirming earlier 25 
observations that employed lower resolution autofluorescence imaging of NAD(P)H [99-101]. 26 
The mechanisms underlying the synchronous propagation of energy status between beta cells 27 
remain unknown, but may reflect Ca2+ feedback and intrinsic metabolic behaviour [96], or 28 
alternatively, metabolic coupling via GJs [102,103].  29 
 30 
In addition to glucose, secretory potentiators, including members of the incretin family, are able 31 
to influence beta cell energetics. The incretin, glucagon-like peptide 1 (GLP-1), is released from 32 
the gut in response to bile transit and glucose-dependently augments insulin secretion [104-106]. 33 
While its effects on cAMP-Epac2, MAPK and beta-arrestin signaling pathways are well-34 
characterised [107-109], little is known about whether GLP-1 alters the beta cell metabolic 35 
 9 
setpoint to influence ATP:ADP. Whereas luciferase-based studies by us have demonstrated a role 1 
for GLP-1 in mitochondrial ATP synthesis in clonal MIN6 beta cells [110], others have observed 2 
no effect of the incretin in rodent islets using biochemical detection methods [111]. Since ATP 3 
dynamics and/or cell heterogeneity may mask actions of incretin on metabolism, the effects of 4 
GLP-1 on intracellular free ATP:ADP were monitored with cellular resolution by expressing the 5 
recombinant probe Perceval throughout the first few layers of rodent and human islets [8,55,112]. 6 
Using these methods, we found that GLP-1 engages a metabolically-coupled subnetwork of beta 7 
cells to amplify insulin secretion, an action that is dependent upon Ca2+ influx and elevations in 8 
cAMP [55]. Of note, in these studies, beta cells within mouse islets responded coordinately to 9 
GLP-1 with synchronous ATP:ADP oscillations, whereas human islets exhibited more random 10 
dynamics. Thus, the regulation of beta cell-beta cell metabolic connectivity may potentially 11 
contribute to the disparate actions of incretin in rodents and man, although confirmation of this 12 
will require simultaneous measures of Ca2+ and ATP:ADP in islets of both species.  13 
 14 
Glucose- and GLP-1-regulated connectivity: Ca2+ signals 15 
Ca2+-imaging of pancreatic islet slices has revealed that glucose likely drives large-scale increases 16 
in population synchrony by coaxing activity in a scale-free and small-world network of beta cells 17 
[29,30,49]. Notably, propagation of Ca2+ waves via GJs is hypothesised to underlie islet dynamics 18 
in response to glucose, since the length of individual correlated links depends on Euclidean 19 
distance, although long-range communications are still evident [29]. Confirming these findings, 20 
we have recently shown that the rapid (ms) oscillations in electrical activity are similarly dictated 21 
by scale-free and small-world beta cell wiring patterns [113]. Thus, under conditions of high 22 
glucose, beta cells work together as defined subpopulations to orchestrate and drive insulin 23 
release from the islet.  24 
 25 
As well as glucose, insulin secretion is also reliant upon the amplifying or potentiating actions of 26 
incretins. Indeed, in humans, almost 70% of the insulin-raising effects of oral glucose challenge 27 
can be attributed to the incretin effect [114]. Notably, the insulinotropic activity of exogenously-28 
administered GIP and GLP-1 is diminished in T2DM [115,116], suggesting that altered beta cell 29 
incretin responsiveness may contribute to the disease state, although causality is not well defined 30 
[117]. Since the single biggest T2DM risk factor remains obesity, and high BMI individuals 31 
present with reduced GLP-1-stimulated insulin secretion [118,119], excess lipid may target 32 
incretin action to impair beta cell function. To investigate this, we subjected human islets to fMCI 33 
to map population dynamics, and found that both GIP and GLP-1 recruit a highly coordinated 34 
subnetwork of GJ-coupled beta cells to augment insulin secretion [27,28]. This process of 35 
 10 
incretin-regulated beta cell connectivity may be a target for the insulin-lowering effects of free 1 
fatty acid (FFA), since it could be disrupted in a GJ-dependent manner following exposure to a 2 
lipotoxic milieu, and was inversely correlated with donor BMI [27]. Mechanistically, this may 3 
involve FFA-induced overexpression of inducible cAMP early repressor gamma (ICER-γ), a 4 
protein that binds a cAMP-response element in the Cx36 promoter [120,121]. By contrast, a 5 
similar effect of incretin on beta cell interactivity was not present in mouse islets, but could be 6 
revealed by placing mice on a high fat diet to disrupt normal glucose responses [27,28]. We 7 
therefore speculate that such divergent regulation of the incretin axis, potentially stemming from 8 
structural and functional differences in islet architecture, may represent a novel target for pro-9 
diabetogenic insults in man. 10 
 11 
Genes and connectivity 12 
Type 2 diabetes has a strong hereditary component [122-124]. Consequently, genome wide 13 
association studies (GWAS) have identified a number of gene variants linked with an increased 14 
odds ratio (OR) of developing elevated fasting glucose and T2DM. Although the effects of these 15 
variants are usually quite small, their very existence indicates that genes in the associated loci are 16 
highly likely to play a role in disease aetiology [125,126]. While gene variants and glucose 17 
homeostasis are well studied in man, relatively less is known about their precise mechanisms of 18 
action at the islet level [125], and in particular upon beta cell connectivity. Several dozen (>90) 19 
risk-associated polymorphisms have been identified to date, and those with the strongest OR for 20 
development of T2DM, or with known effects on beta cell-cell communication, are discussed 21 
below (see Figure 3):  22 
 23 
TCF7L2: TCF7L2 is a member of the canonical Wnt-signaling pathway and a transcriptional 24 
partner for beta-catenin. Individuals who possess a single nucleotide polymorphism (SNP), 25 
rs7903146, in intron 3 of the TCFL72 gene on chromosome 10, have an increased risk of 26 
developing T2DM, with an OR of 1.45 for the T allele [127-130]. This is believed largely to be 27 
due to defects in insulin secretion (insulin sensitivity is slightly impaired in T allele carriers), as 28 
well as a markedly (~50%) attenuated incretin effect [127,131,132] (though see [125] for a 29 
discussion of a role for hepatic glucose handling). Although the subject of debate, these results 30 
have subsequently been confirmed in conditional rodent models and human islets. Thus, TCF7L2 31 
silencing leads to impaired insulin secretion from isolated mouse and human islets [133,134], and 32 
deletion of Tcf7l2 throughout the pancreas or selectively in the beta cell causes glucose 33 
intolerance [135,136], particularly after oral glucose administration, with the observed effects 34 
increasing with age or exposure to a high fat diet (HFD). Of note, a further study failed to detect 35 
 11 
any effects on glycemia of deleting Tcf7l2 in the adult beta cell, although this report was 1 
restricted to examination of intraperitoneal glucose tolerance in young (<12 wks) animals [137]. 2 
GLP-1-stimulated insulin secretion is strongly inhibited by Tcf7l2 elimination in vitro [134,135], 3 
the latter due largely to reduced GLP-1R expression and defects in the exocytotic apparatus 4 
[133,135,138,139]. Interestingly, when investigated in dissociated islets, TCF7L2 knockdown 5 
leads to a slight potentiation of glucose-induced Ca2+ increases [133,140], although only single 6 
(or clusters) of beta cells were studied, precluding analysis of synchrony or coordination. By 7 
contrast, ablation of the Tcf7l2 gene selectively in the beta cell through Ins1Cre-directed 8 
recombination of flox’d alleles impairs these increases when assessed in the intact islet setting 9 
[136]. The reasons for these differences remain obscure but suggest that either silencing in non-10 
beta cells in the former case, or altered beta cell-beta cell interactions in the latter, are at play. Of 11 
note, Tcf7l2 silencing in INS1 cells lowers the expression of Ca2+ channel subunits [141], 12 
suggesting that TCF7L2 may exert control, either directly or indirectly, over the Ca2+-signaling 13 
machinery. Of relevance, when studied in islets from mice maintained on a high fat diet (HFD), 14 
glucose-stimulated beta cell connectivity in Tcf7l2 null animals was significantly reduced versus 15 
that of control animals [136] (manuscript submitted). Of note, this alteration was not associated 16 
with any changes in GJ mRNA expression, though may conceivably involve changes in Cx36 17 
protein abundance.  18 
 19 
ADCY5: ADCY5 gene products encode isoform V of the adenylate cylase family, a type III Ca2+-20 
inhibited enzyme tasked with generation of cAMP [142,143], a second messenger involved in 21 
glucoregulation as part of the “amplifying” pathway [144]. Whereas other isoforms predominate 22 
in the rodent islet, ADCY5 is amongst the most abundant members of this family in human beta 23 
cells [26,145]. The T2DM-associated SNP rs11708067 on chromosome 3 lies within intron 3 of 24 
the ADCY5 gene and is associated with increased fasting glucose and 2-hour glucose, but not oral 25 
glucose responses [146], with an OR of 1.23 for the major A-allele [147]. Using lentiviral shRNA 26 
approaches to silence gene and protein expression in human islets, we have recently shown that 27 
ADCY5 is required for the coupling of glucose but not incretin to insulin secretion [148]. 28 
Although the former is partly due to impaired insulin processing (i.e. proinsulin  insulin 29 
conversion) [149], islets depleted for ADCY5 also displayed impaired glucose- but not GLP-1-30 
induced increases in cAMP, and consequent impairments in glucose-induced metabolism 31 
(ATP:ADP ratios). Moreover, ADCY5-silenced islets showed more stochastic long-term 32 
evolutions in coordinated beta cell activity following glucose exposure [148]. By contrast, GLP-33 
1-regulated connectivity was normal, suggesting that ADCY5 is unlikely to link incretin signaling 34 
to cAMP generation and beta cell communication. Thus, ADCY5 preferentially affects glucose-35 
 12 
induced human islet dynamics, possibly through cAMP, which has been shown to increase GJ 1 
conductance and trafficking [22,73,150], although this has only been so far demonstrated in 2 
rodent tissues.  3 
 4 
ZnT8: The R325W variant of SLC30A8, the gene encoding zinc transporter 8 (ZnT8), is 5 
associated with reduced insulin secretion. ZnT8 is highly expressed in beta cells where its 6 
activation leads to Zn2+ accumulation in secretory granules, promoting normal insulin 7 
crystallization, storage and processing [151-154]. While global ZnT8 deletion results in mild 8 
insulin secretory deficits, which are only observed in vivo and are undetectable at the dispersed 9 
islet level [151,152], beta-cell specific deletion of the same gene has been reported either to 10 
inhibit [153] or stimulate [155] insulin release from isolated islets. Indeed, it has been suggested 11 
that defects in glycemia resulting from either global or beta cell specific ZnT8 elimination 12 
[152,153,155] are due to enhanced insulin clearance by the liver [155]. In any case, and 13 
complicating the picture further, rare loss-of-function mutations in SLC30A8 protect against 14 
T2DM in man [156]. Nonetheless, alterations in ZnT8 expression lead to altered Ca2+/Zn2+-15 
handling [133,152,157], and GJ gating is dependent on fine-regulation of both ions in the vicinity 16 
of the plasma membrane [158,159]; whether this also applies to islets is unknown. Thus, while an 17 
effect of ZnT8 risk alleles on beta cell-beta cell connectivity is not entirely implausible, further 18 
studies are required to assess effects of the gene on coordinated activity and the mechanisms 19 
underlying this (e.g. changes in Cx36 expression or GJ function).  20 
 21 
It should be noted that the studies concerning ADCY5, TCF7L2 and beta cell connectivity were 22 
conducted on models in which expression has essentially been eliminated (through gene silencing 23 
or genomic deletion). It is likely that any phenotype observed in vivo in man is a consequence of 24 
more subtle cellular changes coupled with exposure to a permissive environment. It remains to be 25 
seen whether similar effects can be recapitulated in tissue obtained from normoglycemic donors 26 
harboring specific risk alleles. Lastly, even the strongest GWAS hits only marginally contribute 27 
to T2DM risk and effects of gene variants on beta cell coordination should not be overinterpreted 28 
in the absence of defined mechanisms/targets.  29 
 30 
Rescuing beta cell connectivity during T2DM 31 
Since the intraislet regulation of insulin release may be altered by both genes and the environment 32 
to reduce insulin secretion, beta cell connectivity may represent a novel target for the 33 
pharmaceutical restoration of functional beta cell mass. While up-regulated GJ-signaling provides 34 
a logical starting point for the enhancement of beta cell connectivity, investigation of Cx36-35 
 13 
modulating compounds has so far been complicated by their off-target effects. Notwithstanding, a 1 
recent study has described a panel of seventeen molecules that increase beta cell-beta cell 2 
communication, and further screening is warranted to validate their activity profiles and 3 
specificity [160]. In addition, atlases of both GPCR and paracrine factor expression/secretion 4 
have been reported for human and rodent islets [94,161], potentially accelerating the elucidation 5 
and development of putative candidates for manipulation of beta cell connectivity. Alternatively, 6 
personalized medicine/deep-phenotyping approaches [162] could be used to identify individuals 7 
where the beneficial effects of GLP-1 and GIP to enhance beta cell connectivity may be exploited 8 
[27,28]. For example, carriers of ADCY5 risk alleles are predicted to respond well to the insulin-9 
raising actions of the incretins, as this gene preferentially impacts glucose action [148]. By 10 
contrast, obese subjects would potentially benefit more from the pro-communicatory effects of 11 
the sulfonylureas due to altered GLP-1 and GIP signaling inputs [27,163,164] 12 
 13 
Future perspectives 14 
The network description of beta cells is still in its infancy and more refined methods are required 15 
to better delineate connection topology. Without statistical methods such as Granger causality it 16 
is impossible to say whether coordinated behavior in an individual cell is the origin or 17 
consequence of the connections it shares with its neighbours [42,165]. Likewise, our 18 
understanding of the structural basis for functional connectivity is presently lacking and imaging 19 
approaches are required that allow the large-scale interrogation of any underlying physical cell-20 
cell linkages. This is particularly applicable to human islets, where differences in architecture 21 
may lead to divergent regulation of insulin secretion and susceptibility to T2DM insults 22 
[28,37,64]. Lastly, it remains unknown how beta cell population dynamics are influenced by 23 
episodes of functional/pathological plasticity in the pancreas, and whether a wiring footprint 24 
persists during T2DM that can be exploited to restore insulin secretion.  25 
 26 
Summary 27 
The three-dimensional organization of beta cells into islets produces a gain-of-function in insulin 28 
release by fine-tuning beta cell intercommunication. Each islet operates as a self-supported 29 
signaling unit in which the spatiotemporally-precise propagation of information between 30 
neighboring and distant cell ensembles is facilitated by GJ, neural and paracrine communications. 31 
Using imaging approaches together with statistical methods borne from graph theory, the flow of 32 
information throughout the beta cell population can be monitored online and mapped. Pertinently, 33 
coordinated activity in rodent islets appears to be driven and orchestrated by a subpopulation of 34 
beta cells, and wiring density can be increased by both glucose and incretin to stimulate hormone 35 
 14 
release. We therefore propose that, alongside “cell autonomous” effects, environmental and 1 
genetic insults may target the intraislet regulation of insulin secretion to precipitate beta cell 2 
dysfunction and glucose intolerance, contributing to the risk of developing T2DM.  3 
4 
 15 
REFERENCES 1 
1. International Diabetes Federation. IDF Diabetes Atlas, 5th edn 2 
2. Currie CJ, Poole CD, Gale EA (2009) The influence of glucose-lowering therapies on cancer risk in 3 
type 2 diabetes. Diabetologia 52 (9):1766-1777. doi:10.1007/s00125-009-1440-6 4 
3. Stitt AW (2010) AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci 51 (10):4867-4874. 5 
doi:10.1167/iovs.10-5881 6 
4. van de Bunt M, Gloyn AL (2012) A tale of two glucose transporters: how GLUT2 re-emerged as a 7 
contender for glucose transport into the human beta cell. Diabetologia 55 (9):2312-2315. 8 
doi:10.1007/s00125-012-2612-3 9 
5. Iynedjian PB (1993) Mammalian glucokinase and its gene. Biochem J 293 ( Pt 1):1-13 10 
6. Prentki M, Matschinsky FM, Madiraju SR (2013) Metabolic signaling in fuel-induced insulin 11 
secretion. Cell Metab 18 (2):162-185. doi:10.1016/j.cmet.2013.05.018 12 
7. Rutter GA (2001) Nutrient-secretion coupling in the pancreatic islet beta-cell: recent advances. Mol 13 
Aspects Med 22 (6):247-284 14 
8. Tarasov AI, Semplici F, Ravier MA, Bellomo EA, Pullen TJ, Gilon P, Sekler I, Rizzuto R, Rutter 15 
GA (2012) The mitochondrial Ca2+ uniporter MCU is essential for glucose-induced ATP increases in 16 
pancreatic beta-cells. PLoS One 7 (7):e39722. doi:10.1371/journal.pone.0039722 17 
9. Kennedy HJ, Pouli AE, Ainscow EK, Jouaville LS, Rizzuto R, Rutter GA (1999) Glucose generates 18 
sub-plasma membrane ATP microdomains in single islet beta-cells. Potential role for strategically 19 
located mitochondria. The Journal of biological chemistry 274 (19):13281-13291 20 
10. Ashcroft FM, Harrison DE, Ashcroft SJ (1984) Glucose induces closure of single potassium 21 
channels in isolated rat pancreatic beta-cells. Nature 312 (5993):446-448 22 
11. Ashcroft FM, Gribble FM (1999) ATP-sensitive K+ channels and insulin secretion: their role in 23 
health and disease. Diabetologia 42 (8):903-919. doi:10.1007/s001250051247 24 
12. Ammala C, Ashcroft FM, Rorsman P (1993) Calcium-independent potentiation of insulin release 25 
by cyclic AMP in single beta-cells. Nature 363 (6427):356-358. doi:10.1038/363356a0 26 
13. Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by 27 
glucose. Diabetes 49 (11):1751-1760 28 
14. Rutter GA, Tsuboi T, Ravier MA (2006) Ca2+ microdomains and the control of insulin secretion. 29 
Cell Calcium 40 (5-6):539-551. doi:10.1016/j.ceca.2006.08.015 30 
15. Emmanouilidou E, Teschemacher AG, Pouli AE, Nicholls LI, Seward EP, Rutter GA (1999) 31 
Imaging Ca2+ concentration changes at the secretory vesicle surface with a recombinant targeted 32 
cameleon. Current biology : CB 9 (16):915-918 33 
16. Tsuboi T, Rutter GA (2003) Multiple forms of "kiss-and-run" exocytosis revealed by evanescent 34 
wave microscopy. Curr Biol 13 (7):563-567 35 
17. Rutter GA, Varadi A, Tsuboi T, Parton L, Ravier M (2006) Insulin secretion in health and disease: 36 
genomics, proteomics and single vesicle dynamics. Biochem Soc Trans 34 (Pt 2):247-250. 37 
doi:10.1042/BST20060247 38 
18. Serre-Beinier V, Mas C, Calabrese A, Caton D, Bauquis J, Caille D, Charollais A, Cirulli V, Meda 39 
P (2002) Connexins and secretion. Biol Cell 94 (7-8):477-492. doi:S0248490002000242 [pii] 40 
19. Bavamian S, Klee P, Britan A, Populaire C, Caille D, Cancela J, Charollais A, Meda P (2007) 41 
Islet-cell-to-cell communication as basis for normal insulin secretion. Diabetes Obes Metab 9 Suppl 42 
2:118-132. doi:10.1111/j.1463-1326.2007.00780.x 43 
20. Bosco D, Haefliger JA, Meda P (2011) Connexins: key mediators of endocrine function. Physiol 44 
Rev 91 (4):1393-1445. doi:10.1152/physrev.00027.2010 45 
21. Meda P (2013) Protein-mediated interactions of pancreatic islet cells. Scientifica (Cairo) 46 
2013:621249. doi:10.1155/2013/621249 47 
22. Farnsworth NL, Benninger RK (2014) New insights into the role of connexins in pancreatic islet 48 
function and diabetes. FEBS Lett 588 (8):1278-1287. doi:10.1016/j.febslet.2014.02.035 49 
23. Salomon D, Meda P (1986) Heterogeneity and contact-dependent regulation of hormone secretion 50 
by individual B cells. Exp Cell Res 162 (2):507-520 51 
24. Caton D, Calabrese A, Mas C, Serre-Beinier V, Wonkam A, Meda P (2002) Beta-cell crosstalk: a 52 
further dimension in the stimulus-secretion coupling of glucose-induced insulin release. Diabetes 53 
Metab 28 (6 Pt 2):3S45-53; discussion 43S108-112 54 
 16 
25. Steiner DJ, Kim A, Miller K, Hara M (2010) Pancreatic islet plasticity: interspecies comparison of 1 
islet architecture and composition. Islets 2 (3):135-145 2 
26. Hodson DJ, Mitchell RK, Marselli L, Pullen TJ, Brias SG, Semplici F, Everett KL, Cooper DM, 3 
Bugliani M, Marchetti P, Lavallard V, Bosco D, Piemonti L, Johnson PR, Hughes SJ, Li D, Li WH, 4 
Shapiro AM, Rutter GA (2014) ADCY5 couples glucose to insulin secretion in human islets. 5 
Diabetes. doi:10.2337/db13-1607 6 
27. Hodson DJ, Mitchell RK, Bellomo EA, Sun G, Vinet L, Meda P, Li D, Li WH, Bugliani M, 7 
Marchetti P, Bosco D, Piemonti L, Johnson P, Hughes SJ, Rutter GA (2013) Lipotoxicity disrupts 8 
incretin-regulated human beta cell connectivity. J Clin Invest 123 (10):4182-4194. 9 
doi:10.1172/JCI68459 10 
28. Rutter GA, Hodson DJ (2013) Minireview: intraislet regulation of insulin secretion in humans. 11 
Mol Endocrinol 27 (12):1984-1995. doi:10.1210/me.2013-1278 12 
29. Stozer A, Gosak M, Dolensek J, Perc M, Marhl M, Rupnik MS, Korosak D (2013) Functional 13 
connectivity in islets of Langerhans from mouse pancreas tissue slices. PLoS Comput Biol 9 14 
(2):e1002923. doi:10.1371/journal.pcbi.1002923 15 
30. Stozer A, Dolensek J, Rupnik MS (2013) Glucose-stimulated calcium dynamics in islets of 16 
Langerhans in acute mouse pancreas tissue slices. PLoS One 8 (1):e54638. 17 
doi:10.1371/journal.pone.0054638 18 
31. Benninger RK, Piston DW (2014) Cellular communication and heterogeneity in pancreatic islet 19 
insulin secretion dynamics. Trends Endocrinol Metab. doi:10.1016/j.tem.2014.02.005 20 
32. Orci L, Unger RH (1975) Functional subdivision of islets of Langerhans and possible role of D 21 
cells. Lancet 2 (7947):1243-1244 22 
33. Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A (2006) The unique 23 
cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci 24 
U S A 103 (7):2334-2339. doi:0510790103 [pii] 25 
10.1073/pnas.0510790103 26 
34. Nyman LR, Wells KS, Head WS, McCaughey M, Ford E, Brissova M, Piston DW, Powers AC 27 
(2008) Real-time, multidimensional in vivo imaging used to investigate blood flow in mouse 28 
pancreatic islets. J Clin Invest 118 (11):3790-3797. doi:10.1172/JCI36209 29 
35. Cleaver O, Dor Y (2012) Vascular instruction of pancreas development. Development 139 30 
(16):2833-2843. doi:10.1242/dev.065953 31 
36. Brissova M, Fowler MJ, Nicholson WE, Chu A, Hirshberg B, Harlan DM, Powers AC (2005) 32 
Assessment of human pancreatic islet architecture and composition by laser scanning confocal 33 
microscopy. J Histochem Cytochem 53 (9):1087-1097. doi:jhc.5C6684.2005 [pii] 34 
10.1369/jhc.5C6684.2005 35 
37. Bosco D, Armanet M, Morel P, Niclauss N, Sgroi A, Muller YD, Giovannoni L, Parnaud G, 36 
Berney T (2010) Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes 37 
59 (5):1202-1210. doi:10.2337/db09-1177 38 
38. Kilimnik G, Zhao B, Jo J, Periwal V, Witkowski P, Misawa R, Hara M (2011) Altered islet 39 
composition and disproportionate loss of large islets in patients with type 2 diabetes. PLoS One 6 40 
(11):e27445. doi:10.1371/journal.pone.0027445 41 
39. Halban PA, Wollheim CB, Blondel B, Meda P, Niesor EN, Mintz DH (1982) The possible 42 
importance of contact between pancreatic islet cells for the control of insulin release. Endocrinology 43 
111 (1):86-94. doi:10.1210/endo-111-1-86 44 
40. Hauge-Evans AC, Squires PE, Persaud SJ, Jones PM (1999) Pancreatic beta-cell-to-beta-cell 45 
interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin 46 
secretory responses of MIN6 pseudoislets. Diabetes 48 (7):1402-1408 47 
41. Squires PE, Hauge-Evans AC, Persaud SJ, Jones PM (2000) Synchronization of Ca(2+)-signals 48 
within insulin-secreting pseudoislets: effects of gap-junctional uncouplers. Cell Calcium 27 (5):287-49 
296. doi:10.1054/ceca.2000.0117 50 
42. Hodson DJ, Molino F, Fontanaud P, Bonnefont X, Mollard P (2010) Investigating and Modelling 51 
Pituitary Endocrine Network Function. J Neuroendocrinol (22):1217-1225. doi:JNE2052 [pii] 52 
10.1111/j.1365-2826.2010.02052.x 53 
 17 
43. Takahashi N, Kishimoto T, Nemoto T, Kadowaki T, Kasai H (2002) Fusion pore dynamics and 1 
insulin granule exocytosis in the pancreatic islet. Science 297 (5585):1349-1352. 2 
doi:10.1126/science.1073806 3 
44. Li D, Chen S, Bellomo EA, Tarasov AI, Kaut C, Rutter GA, Li WH (2011) Imaging dynamic 4 
insulin release using a fluorescent zinc indicator for monitoring induced exocytotic release (ZIMIR). 5 
Proc Natl Acad Sci U S A 108 (52):21063-21068. doi:10.1073/pnas.1109773109 6 
45. Low JT, Mitchell JM, Do OH, Bax J, Rawlings A, Zavortink M, Morgan G, Parton RG, Gaisano 7 
HY, Thorn P (2013) Glucose principally regulates insulin secretion in mouse islets by controlling the 8 
numbers of granule fusion events per cell. Diabetologia 56 (12):2629-2637. doi:10.1007/s00125-013-9 
3019-5 10 
46. Pancholi J, Hodson DJ, Jobe K, Rutter GA, Goldup SM, Watkinson M (2014) Biologically 11 
targeted probes for Zn2+: a diversity oriented modular “click-SNAr-click” approach. Chemical 12 
Science. doi:10.1039/c4sc01249f 13 
47. Akemann W, Mutoh H, Perron A, Rossier J, Knopfel T (2010) Imaging brain electric signals with 14 
genetically targeted voltage-sensitive fluorescent proteins. Nat Methods 7 (8):643-649. 15 
doi:10.1038/nmeth.1479 16 
48. Hodson DJ, Romano N, Schaeffer M, Fontanaud P, Lafont C, Fiordelisio T, Mollard P (2012) 17 
Coordination of calcium signals by pituitary endocrine cells in situ. Cell Calcium 51 (3-4):222-230. 18 
doi:10.1016/j.ceca.2011.11.007 19 
49. Dolensek J, Stozer A, Skelin Klemen M, Miller EW, Slak Rupnik M (2013) The relationship 20 
between membrane potential and calcium dynamics in glucose-stimulated beta cell syncytium in acute 21 
mouse pancreas tissue slices. PLoS One 8 (12):e82374. doi:10.1371/journal.pone.0082374 22 
50. Schlegel W, Winiger BP, Mollard P, Vacher P, Wuarin F, Zahnd GR, Wollheim CB, Dufy B 23 
(1987) Oscillations of cytosolic Ca2+ in pituitary cells due to action potentials. Nature 329 24 
(6141):719-721. doi:10.1038/329719a0 25 
51. Peterlin ZA, Kozloski J, Mao BQ, Tsiola A, Yuste R (2000) Optical probing of neuronal circuits 26 
with calcium indicators. Proc Natl Acad Sci U S A 97 (7):3619-3624. doi:97/7/3619 [pii] 27 
52. Cossart R, Ikegaya Y, Yuste R (2005) Calcium imaging of cortical networks dynamics. Cell 28 
Calcium 37 (5):451-457. doi:S0143-4160(05)00030-8 [pii] 29 
10.1016/j.ceca.2005.01.013 30 
53. Ikegaya Y, Le Bon-Jego M, Yuste R (2005) Large-scale imaging of cortical network activity with 31 
calcium indicators. Neurosci Res 52 (2):132-138. doi:S0168-0102(05)00063-5 [pii] 32 
10.1016/j.neures.2005.02.004 33 
54. Hodson DJ, Schaeffer M, Romano N, Fontanaud P, Lafont C, Birkenstock J, Molino F, Christian 34 
H, Lockey J, Carmignac D, Fernandez-Fuente M, Le Tissier P, Mollard P (2012) Existence of long-35 
lasting experience-dependent plasticity in endocrine cell networks. Nature Communications 3:605. 36 
doi:10.1038/ncomms1612 37 
55. Hodson DJ, Tarasov AI, Gimeno Brias S, Mitchell RK, Johnston NR, Haghollahi S, Cane MC, 38 
Bugliani M, Marchetti P, Bosco D, Johnson PR, Hughes SJ, Rutter GA (2014) Incretin-modulated 39 
beta cell energetics in intact islets of Langerhans. Mol Endocrinol:me20141038. 40 
doi:10.1210/me.2014-1038 41 
56. Alon U (2007) Network motifs: theory and experimental approaches. Nature Reviews Genetics 8 42 
(6):450-461. doi:10.1038/nrg2102 43 
57. Bullmore E, Sporns O (2009) Complex brain networks: graph theoretical analysis of structural and 44 
functional systems. Nat Rev Neurosci 10 (3):186-198. doi:10.1038/nrn2575 45 
58. Price DJ (1965) Networks of Scientific Papers. Science 149:510-515 46 
59. Barabasi AL, Albert R (1999) Emergence of scaling in random networks. Science 286 (5439):509-47 
512. doi:7898 [pii] 48 
60. Barabasi AL (2009) Scale-free networks: a decade and beyond. Science 325 (5939):412-413. 49 
doi:325/5939/412 [pii] 50 
10.1126/science.1173299 51 
61. Bonifazi P, Goldin M, Picardo MA, Jorquera I, Cattani A, Bianconi G, Represa A, Ben-Ari Y, 52 
Cossart R (2009) GABAergic hub neurons orchestrate synchrony in developing hippocampal 53 
networks. Science 326 (5958):1419-1424. doi:326/5958/1419 [pii] 54 
10.1126/science.1175509 55 
 18 
62. Mollard P, Hodson DJ, Lafont C, Rizzoti K, Drouin J (2012) A tridimensional view of pituitary 1 
development and function. Trends Endocrinol Metab. doi:10.1016/j.tem.2012.02.004 2 
63. Le Tissier PR, Hodson DJ, Lafont C, Fontanaud P, Schaeffer M, Mollard P (2012) Anterior 3 
pituitary cell networks. Front Neuroendocrinol 33 (3):252-266. doi:10.1016/j.yfrne.2012.08.002 4 
64. Caicedo A (2013) Paracrine and autocrine interactions in the human islet: more than meets the 5 
eye. Semin Cell Dev Biol 24 (1):11-21. doi:10.1016/j.semcdb.2012.09.007 6 
65. Serre-Beinier V, Le Gurun S, Belluardo N, Trovato-Salinaro A, Charollais A, Haefliger JA, 7 
Condorelli DF, Meda P (2000) Cx36 preferentially connects beta-cells within pancreatic islets. 8 
Diabetes 49 (5):727-734 9 
66. Condorelli DF, Belluardo N, Trovato-Salinaro A, Mudo G (2000) Expression of Cx36 in 10 
mammalian neurons. Brain Res Brain Res Rev 32 (1):72-85. doi:S0165017399000685 [pii] 11 
67. Charpantier E, Cancela J, Meda P (2007) Beta cells preferentially exchange cationic molecules via 12 
connexin 36 gap junction channels. Diabetologia 50 (11):2332-2341. doi:10.1007/s00125-007-0807-9 13 
68. Ravier MA, Guldenagel M, Charollais A, Gjinovci A, Caille D, Sohl G, Wollheim CB, Willecke 14 
K, Henquin JC, Meda P (2005) Loss of connexin36 channels alters beta-cell coupling, islet 15 
synchronization of glucose-induced Ca2+ and insulin oscillations, and basal insulin release. Diabetes 16 
54 (6):1798-1807. doi:54/6/1798 [pii] 17 
69. Speier S, Gjinovci A, Charollais A, Meda P, Rupnik M (2007) Cx36-mediated coupling reduces 18 
beta-cell heterogeneity, confines the stimulating glucose concentration range, and affects insulin 19 
release kinetics. Diabetes 56 (4):1078-1086. doi:10.2337/db06-0232 20 
70. Rocheleau JV, Remedi MS, Granada B, Head WS, Koster JC, Nichols CG, Piston DW (2006) 21 
Critical role of gap junction coupled KATP channel activity for regulated insulin secretion. PLoS 22 
Biology 4 (2):e26. doi:05-PLBI-RA-0819R2 [pii] 23 
10.1371/journal.pbio.0040026 24 
71. Head WS, Orseth ML, Nunemaker CS, Satin LS, Piston DW, Benninger RK (2012) Connexin-36 25 
gap junctions regulate in vivo first- and second-phase insulin secretion dynamics and glucose 26 
tolerance in the conscious mouse. Diabetes 61 (7):1700-1707. doi:10.2337/db11-1312 27 
72. Serre-Beinier V, Bosco D, Zulianello L, Charollais A, Caille D, Charpantier E, Gauthier BR, 28 
Diaferia GR, Giepmans BN, Lupi R, Marchetti P, Deng S, Buhler L, Berney T, Cirulli V, Meda P 29 
(2009) Cx36 makes channels coupling human pancreatic beta-cells, and correlates with insulin 30 
expression. Hum Mol Genet 18 (3):428-439. doi:10.1093/hmg/ddn370 31 
73. Farnsworth NL, Hemmati A, Pozzoli M, Benninger RK (2014) Fluorescence recovery after 32 
photobleaching reveals regulation and distribution of Cx36 gap junction coupling within mouse islets 33 
of langerhans. J Physiol. doi:10.1113/jphysiol.2014.276733 34 
74. Ahren B (2000) Autonomic regulation of islet hormone secretion--implications for health and 35 
disease. Diabetologia 43 (4):393-410. doi:10.1007/s001250051322 36 
75. Zhang M, Fendler B, Peercy B, Goel P, Bertram R, Sherman A, Satin L (2008) Long lasting 37 
synchronization of calcium oscillations by cholinergic stimulation in isolated pancreatic islets. 38 
Biophys J 95 (10):4676-4688. doi:S0006-3495(08)78607-7 [pii] 39 
10.1529/biophysj.107.125088 40 
76. Fendler B, Zhang M, Satin L, Bertram R (2009) Synchronization of pancreatic islet oscillations by 41 
intrapancreatic ganglia: a modeling study. Biophys J 97 (3):722-729. doi:10.1016/j.bpj.2009.05.016 42 
77. Ahren B, Holst JJ (2001) The cephalic insulin response to meal ingestion in humans is dependent 43 
on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. 44 
Diabetes 50 (5):1030-1038 45 
78. Filipsson K, Kvist-Reimer M, Ahren B (2001) The neuropeptide pituitary adenylate cyclase-46 
activating polypeptide and islet function. Diabetes 50 (9):1959-1969 47 
79. Kurose T, Seino Y, Nishi S, Tsuji K, Taminato T, Tsuda K, Imura H (1990) Mechanism of 48 
sympathetic neural regulation of insulin, somatostatin, and glucagon secretion. Am J Physiol 258 (1 Pt 49 
1):E220-227 50 
80. Nilsson T, Arkhammar P, Rorsman P, Berggren PO (1988) Inhibition of glucose-stimulated 51 
insulin release by alpha 2-adrenoceptor activation is parallelled by both a repolarization and a 52 
reduction in cytoplasmic free Ca2+ concentration. J Biol Chem 263 (4):1855-1860 53 
 19 
81. Kuo WN, Hodgins DS, Kuo JF (1973) Adenylate cyclase in islets of Langerhans. Isolation of 1 
islets and regulation of adenylate cyclase activity by various hormones and agents. J Biol Chem 248 2 
(8):2705-2711 3 
82. Asensio C, Jimenez M, Kuhne F, Rohner-Jeanrenaud F, Muzzin P (2005) The lack of beta-4 
adrenoceptors results in enhanced insulin sensitivity in mice exhibiting increased adiposity and 5 
glucose intolerance. Diabetes 54 (12):3490-3495 6 
83. Rodriguez-Diaz R, Abdulreda MH, Formoso AL, Gans I, Ricordi C, Berggren PO, Caicedo A 7 
(2011) Innervation patterns of autonomic axons in the human endocrine pancreas. Cell Metabolism 14 8 
(1):45-54. doi:10.1016/j.cmet.2011.05.008 9 
84. Rodriguez-Diaz R, Dando R, Jacques-Silva MC, Fachado A, Molina J, Abdulreda MH, Ricordi C, 10 
Roper SD, Berggren PO, Caicedo A (2011) Alpha cells secrete acetylcholine as a non-neuronal 11 
paracrine signal priming beta cell function in humans. Nat Med 17 (7):888-892. doi:10.1038/nm.2371 12 
85. Molina J, Rodriguez-Diaz R, Fachado A, Jacques-Silva MC, Berggren PO, Caicedo A (2014) 13 
Control Of Insulin Secretion By Cholinergic Signaling In The Human Pancreatic Islet. Diabetes. 14 
doi:10.2337/db13-1371 15 
86. Martin F, Soria B (1996) Glucose-induced [Ca2+]i oscillations in single human pancreatic islets. 16 
Cell Calcium 20 (5):409-414 17 
87. diIorio P, Rittenhouse AR, Bortell R, Jurczyk A (2014) Role of cilia in normal pancreas function 18 
and in diseased states. Birth Defects Res C Embryo Today 102 (2):126-138. doi:10.1002/bdrc.21064 19 
88. Oh EC, Katsanis N (2012) Cilia in vertebrate development and disease. Development 139 (3):443-20 
448. doi:10.1242/dev.050054 21 
89. Cano DA, Sekine S, Hebrok M (2006) Primary cilia deletion in pancreatic epithelial cells results 22 
in cyst formation and pancreatitis. Gastroenterology 131 (6):1856-1869. 23 
doi:10.1053/j.gastro.2006.10.050 24 
90. Ait-Lounis A, Baas D, Barras E, Benadiba C, Charollais A, Nlend Nlend R, Liegeois D, Meda P, 25 
Durand B, Reith W (2007) Novel function of the ciliogenic transcription factor RFX3 in development 26 
of the endocrine pancreas. Diabetes 56 (4):950-959. doi:10.2337/db06-1187 27 
91. Granot Z, Swisa A, Magenheim J, Stolovich-Rain M, Fujimoto W, Manduchi E, Miki T, Lennerz 28 
JK, Stoeckert CJ, Jr., Meyuhas O, Seino S, Permutt MA, Piwnica-Worms H, Bardeesy N, Dor Y 29 
(2009) LKB1 regulates pancreatic beta cell size, polarity, and function. Cell Metab 10 (4):296-308. 30 
doi:10.1016/j.cmet.2009.08.010 31 
92. Green JA, Mykytyn K (2014) Neuronal primary cilia: an underappreciated signaling and sensory 32 
organelle in the brain. Neuropsychopharmacology 39 (1):244-245. doi:10.1038/npp.2013.203 33 
93. Wang J, Silva M, Haas LA, Morsci NS, Nguyen KC, Hall DH, Barr MM (2014) C. elegans 34 
ciliated sensory neurons release extracellular vesicles that function in animal communication. Curr 35 
Biol 24 (5):519-525. doi:10.1016/j.cub.2014.01.002 36 
94. Yang YH, Szabat M, Bragagnini C, Kott K, Helgason CD, Hoffman BG, Johnson JD (2011) 37 
Paracrine signalling loops in adult human and mouse pancreatic islets: netrins modulate beta cell 38 
apoptosis signalling via dependence receptors. Diabetologia 54 (4):828-842. doi:10.1007/s00125-010-39 
2012-5 40 
95. Ren J, Sherman A, Bertram R, Goforth PB, Nunemaker CS, Waters CD, Satin LS (2013) Slow 41 
oscillations of KATP conductance in mouse pancreatic islets provide support for electrical bursting 42 
driven by metabolic oscillations. Am J Physiol Endocrinol Metab 305 (7):E805-817. 43 
doi:10.1152/ajpendo.00046.2013 44 
96. Merrins MJ, Fendler B, Zhang M, Sherman A, Bertram R, Satin LS (2010) Metabolic oscillations 45 
in pancreatic islets depend on the intracellular Ca2+ level but not Ca2+ oscillations. Biophys J 99 46 
(1):76-84. doi:10.1016/j.bpj.2010.04.012 47 
97. Nunemaker CS, Satin LS (2004) Comparison of metabolic oscillations from mouse pancreatic 48 
beta cells and islets. Endocrine 25 (1):61-67. doi:ENDO:25:1:61 [pii] 49 
10.1385/ENDO:25:1:61 50 
98. Li J, Shuai HY, Gylfe E, Tengholm A (2013) Oscillations of sub-membrane ATP in glucose-51 
stimulated beta cells depend on negative feedback from Ca(2+). Diabetologia 56 (7):1577-1586. 52 
doi:10.1007/s00125-013-2894-0 53 
99. Bennett BD, Jetton TL, Ying G, Magnuson MA, Piston DW (1996) Quantitative subcellular 54 
imaging of glucose metabolism within intact pancreatic islets. J Biol Chem 271 (7):3647-3651 55 
 20 
100. Piston DW, Knobel SM (1999) Quantitative imaging of metabolism by two-photon excitation 1 
microscopy. Methods Enzymol 307:351-368 2 
101. Nunemaker CS, Dishinger JF, Dula SB, Wu R, Merrins MJ, Reid KR, Sherman A, Kennedy RT, 3 
Satin LS (2009) Glucose metabolism, islet architecture, and genetic homogeneity in imprinting of 4 
[Ca2+](i) and insulin rhythms in mouse islets. PLoS One 4 (12):e8428. 5 
doi:10.1371/journal.pone.0008428 6 
102. Kohen E, Kohen C, Thorell B, Mintz DH, Rabinovitch A (1979) Intercellular communication in 7 
pancreatic islet monolayer cultures: a microfluorometric study. Science 204 (4395):862-865 8 
103. Meda P, Amherdt M, Perrelet A, Orci L (1981) Metabolic coupling between cultured pancreatic 9 
b-cells. Exp Cell Res 133 (2):421-430 10 
104. Reimann F, Gribble FM (2002) Glucose-sensing in glucagon-like peptide-1-secreting cells. 11 
Diabetes 51 (9):2757-2763 12 
105. Tolhurst G, Reimann F, Gribble FM (2009) Nutritional regulation of glucagon-like peptide-1 13 
secretion. J Physiol 587 (Pt 1):27-32. doi:10.1113/jphysiol.2008.164012 14 
106. Parker HE, Wallis K, le Roux CW, Wong KY, Reimann F, Gribble FM (2012) Molecular 15 
mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br J Pharmacol 165 16 
(2):414-423. doi:10.1111/j.1476-5381.2011.01561.x 17 
107. Gomez E, Pritchard C, Herbert TP (2002) cAMP-dependent protein kinase and Ca2+ influx 18 
through L-type voltage-gated calcium channels mediate Raf-independent activation of extracellular 19 
regulated kinase in response to glucagon-like peptide-1 in pancreatic beta-cells. J Biol Chem 277 20 
(50):48146-48151. doi:10.1074/jbc.M209165200 21 
108. Leech CA, Dzhura I, Chepurny OG, Kang G, Schwede F, Genieser HG, Holz GG (2011) 22 
Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic beta cells. 23 
Prog Biophys Mol Biol 107 (2):236-247. doi:10.1016/j.pbiomolbio.2011.07.005 24 
109. Ravier MA, Leduc M, Richard J, Linck N, Varrault A, Pirot N, Roussel MM, Bockaert J, Dalle 25 
S, Bertrand G (2013) beta-Arrestin2 plays a key role in the modulation of the pancreatic beta cell 26 
mass in mice. Diabetologia. doi:10.1007/s00125-013-3130-7 27 
110. Tsuboi T, da Silva Xavier G, Holz GG, Jouaville LS, Thomas AP, Rutter GA (2003) Glucagon-28 
like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic 29 
MIN6 beta-cells. The Biochemical journal 369 (Pt 2):287-299. doi:10.1042/BJ20021288 30 
111. Peyot ML, Gray JP, Lamontagne J, Smith PJ, Holz GG, Madiraju SR, Prentki M, Heart E (2009) 31 
Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy 32 
metabolism in primary rodent pancreatic beta-cells. PLoS One 4 (7):e6221. 33 
doi:10.1371/journal.pone.0006221 34 
112. Berg J, Hung YP, Yellen G (2009) A genetically encoded fluorescent reporter of ATP:ADP ratio. 35 
Nat Methods 6 (2):161-166. doi:10.1038/nmeth.1288 36 
113. Hodson DJ, Mitchell RK, Johnston N, Thorens B, Ferrer J, Rutter GA (2014) Optical control of 37 
beta cell function. Diabet Med 31:6-6 38 
114. Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, Creutzfeldt W (1986) 39 
Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide 40 
responses. J Clin Endocrinol Metab 63 (2):492-498. doi:10.1210/jcem-63-2-492 41 
115. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W (1993) Preserved 42 
incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory 43 
polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91 (1):301-307. 44 
doi:10.1172/JCI116186 45 
116. Kjems LL, Holst JJ, Volund A, Madsbad S (2003) The influence of GLP-1 on glucose-stimulated 46 
insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 52 47 
(2):380-386 48 
117. Meier JJ, Nauck MA (2010) Is the diminished incretin effect in type 2 diabetes just an epi-49 
phenomenon of impaired beta-cell function? Diabetes 59 (5):1117-1125. doi:10.2337/db09-1899 50 
118. Muscelli E, Mari A, Casolaro A, Camastra S, Seghieri G, Gastaldelli A, Holst JJ, Ferrannini E 51 
(2008) Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and 52 
type 2 diabetic patients. Diabetes 57 (5):1340-1348. doi:10.2337/db07-1315 53 
119. Knop FK, Aaboe K, Vilsboll T, Volund A, Holst JJ, Krarup T, Madsbad S (2012) Impaired 54 
incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs 55 
 21 
of dysmetabolism in obesity. Diabetes Obes Metab 14 (6):500-510. doi:10.1111/j.1463-1 
1326.2011.01549.x 2 
120. Allagnat F, Alonso F, Martin D, Abderrahmani A, Waeber G, Haefliger JA (2008) ICER-3 
1gamma overexpression drives palmitate-mediated connexin36 down-regulation in insulin-secreting 4 
cells. J Biol Chem 283 (9):5226-5234. doi:10.1074/jbc.M708181200 5 
121. Haefliger JA, Martin D, Favre D, Petremand Y, Mazzolai L, Abderrahmani A, Meda P, Waeber 6 
G, Allagnat F (2013) Reduction of connexin36 content by ICER-1 contributes to insulin-secreting 7 
cells apoptosis induced by oxidized LDL particles. PLoS One 8 (1):e55198. 8 
doi:10.1371/journal.pone.0055198 9 
122. Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD (1987) Concordance for 10 
type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30 (10):763-768 11 
123. Pierce M, Keen H, Bradley C (1995) Risk of Diabetes in Offspring of Parents with Non-insulin-12 
dependent Diabetes. Diabet Med 12 (1):6-13. doi:10.1111/j.1464-5491.1995.tb02054.x 13 
124. Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD (1999) Concordance rate for type II diabetes 14 
mellitus in monozygotic twins: actuarial analysis. Diabetologia 42 (2):146-150. 15 
doi:10.1007/s001250051132 16 
125. Rutter GA (2014) Understanding genes identified by genome-wide association studies for Type 2 17 
diabetes. Diabet Med. doi:10.1111/dme.12579 18 
126. McCarthy MI (2010) Genomics, type 2 diabetes, and obesity. N Engl J Med 363 (24):2339-2350. 19 
doi:10.1056/NEJMra0906948 20 
127. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, Sjogren M, Ling 21 
C, Eriksson KF, Lethagen AL, Mancarella R, Berglund G, Tuomi T, Nilsson P, Del Prato S, Groop L 22 
(2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J 23 
Clin Invest 117 (8):2155-2163. doi:10.1172/JCI30706 24 
128. Salonen JT, Uimari P, Aalto JM, Pirskanen M, Kaikkonen J, Todorova B, Hypponen J, 25 
Korhonen VP, Asikainen J, Devine C, Tuomainen TP, Luedemann J, Nauck M, Kerner W, Stephens 26 
RH, New JP, Ollier WE, Gibson JM, Payton A, Horan MA, Pendleton N, Mahoney W, Meyre D, 27 
Delplanque J, Froguel P, Luzzatto O, Yakir B, Darvasi A (2007) Type 2 diabetes whole-genome 28 
association study in four populations: the DiaGen consortium. Am J Hum Genet 81 (2):338-345. 29 
doi:10.1086/520599 30 
129. Vaxillaire M, Veslot J, Dina C, Proenca C, Cauchi S, Charpentier G, Tichet J, Fumeron F, Marre 31 
M, Meyre D, Balkau B, Froguel P (2008) Impact of common type 2 diabetes risk polymorphisms in 32 
the DESIR prospective study. Diabetes 57 (1):244-254. doi:10.2337/db07-0615 33 
130. Palmer ND, Lehtinen AB, Langefeld CD, Campbell JK, Haffner SM, Norris JM, Bergman RN, 34 
Goodarzi MO, Rotter JI, Bowden DW (2008) Association of TCF7L2 gene polymorphisms with 35 
reduced acute insulin response in Hispanic Americans. J Clin Endocrinol Metab 93 (1):304-309. 36 
doi:10.1210/jc.2007-1225 37 
131. Schafer SA, Tschritter O, Machicao F, Thamer C, Stefan N, Gallwitz B, Holst JJ, Dekker JM, t 38 
Hart LM, Nijpels G, van Haeften TW, Haring HU, Fritsche A (2007) Impaired glucagon-like peptide-39 
1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. 40 
Diabetologia 50 (12):2443-2450. doi:10.1007/s00125-007-0753-6 41 
132. Pilgaard K, Jensen CB, Schou JH, Lyssenko V, Wegner L, Brons C, Vilsboll T, Hansen T, 42 
Madsbad S, Holst JJ, Volund A, Poulsen P, Groop L, Pedersen O, Vaag AA (2009) The T allele of 43 
rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 44 
h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy 45 
men. Diabetologia 52 (7):1298-1307. doi:10.1007/s00125-009-1307-x 46 
133. da Silva Xavier G, Loder MK, McDonald A, Tarasov AI, Carzaniga R, Kronenberger K, Barg S, 47 
Rutter GA (2009) TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells. 48 
Diabetes 58 (4):894-905. doi:10.2337/db08-1187 49 
134. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J, Maedler K (2008) 50 
Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. 51 
Diabetes 57 (3):645-653. doi:10.2337/db07-0847 52 
135. da Silva Xavier G, Mondragon A, Sun G, Chen L, McGinty JA, French PM, Rutter GA (2012) 53 
Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice. Diabetologia 54 
55 (10):2667-2676. doi:10.1007/s00125-012-2600-7 55 
 22 
136. da Silva Xavier G, Mondragon A, Mitchell RK, Hodson DJ, Ferrer J, Thoren B, Chen L, 1 
McGinty JA, French PM, Rutter GA Defective glucose homeostasis in mice inactivated selectively for 2 
Tcf7l2 in the adult beta cell with  3 
an Ins1-controlled Cre. In: EASD, Vienna, 2014.  4 
137. Boj SF, van Es JH, Huch M, Li VS, Jose A, Hatzis P, Mokry M, Haegebarth A, van den Born M, 5 
Chambon P, Voshol P, Dor Y, Cuppen E, Fillat C, Clevers H (2012) Diabetes Risk Gene and Wnt 6 
Effector Tcf7l2/TCF4 Controls Hepatic Response to Perinatal and Adult Metabolic Demand. Cell 151 7 
(7):1595-1607. doi:10.1016/j.cell.2012.10.053 8 
138. Shu L, Matveyenko AV, Kerr-Conte J, Cho JH, McIntosh CH, Maedler K (2009) Decreased 9 
TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 10 
receptors and impaired beta-cell function. Hum Mol Genet 18 (13):2388-2399. 11 
doi:10.1093/hmg/ddp178 12 
139. Rosengren AH, Braun M, Mahdi T, Andersson SA, Travers ME, Shigeto M, Zhang E, Almgren 13 
P, Ladenvall C, Axelsson AS, Edlund A, Pedersen MG, Jonsson A, Ramracheya R, Tang Y, Walker 14 
JN, Barrett A, Johnson PR, Lyssenko V, McCarthy MI, Groop L, Salehi A, Gloyn AL, Renstrom E, 15 
Rorsman P, Eliasson L (2012) Reduced insulin exocytosis in human pancreatic beta-cells with gene 16 
variants linked to type 2 diabetes. Diabetes 61 (7):1726-1733. doi:10.2337/db11-1516 17 
140. Loder MK, da Silva Xavier G, McDonald A, Rutter GA (2008) TCF7L2 controls insulin gene 18 
expression and insulin secretion in mature pancreatic beta-cells. Biochem Soc Trans 36 (Pt 3):357-19 
359. doi:10.1042/BST0360357 20 
141. Zhou Y, Park SY, Su J, Bailey K, Ottosson-Laakso E, Shcherbina L, Oskolkov N, Zhang E, 21 
Thevenin T, Fadista J, Bennet H, Vikman P, Wierup N, Fex M, Rung J, Wollheim C, Nobrega M, 22 
Renstrom E, Groop L, Hansson O (2014) TCF7L2 is a master regulator of insulin production and 23 
processing. Hum Mol Genet. doi:10.1093/hmg/ddu359 24 
142. Yoshimura M, Cooper DM (1992) Cloning and expression of a Ca(2+)-inhibitable adenylyl 25 
cyclase from NCB-20 cells. Proc Natl Acad Sci U S A 89 (15):6716-6720 26 
143. Yan L, Vatner DE, O'Connor JP, Ivessa A, Ge H, Chen W, Hirotani S, Ishikawa Y, Sadoshima J, 27 
Vatner SF (2007) Type 5 adenylyl cyclase disruption increases longevity and protects against stress. 28 
Cell 130 (2):247-258. doi:10.1016/j.cell.2007.05.038 29 
144. Holz GG, Leech CA, Chepurny OG (2014) New insights concerning the molecular basis for 30 
defective glucoregulation in soluble adenylyl cyclase knockout mice. Biochim Biophys Acta. 31 
doi:10.1016/j.bbadis.2014.06.023 32 
145. Leech CA, Castonguay MA, Habener JF (1999) Expression of adenylyl cyclase subtypes in 33 
pancreatic beta-cells. Biochem Biophys Res Commun 254 (3):703-706. doi:10.1006/bbrc.1998.9906 34 
146. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer 35 
NL, Bouatia-Naji N, Gloyn AL, Lindgren CM, Magi R, Morris AP, Randall J, Johnson T, Elliott P, 36 
Rybin D, Thorleifsson G, Steinthorsdottir V, Henneman P, Grallert H, Dehghan A, Hottenga JJ, 37 
Franklin CS, Navarro P, Song K, Goel A, Perry JR, Egan JM, Lajunen T, Grarup N, Sparso T, Doney 38 
A, Voight BF, Stringham HM, Li M, Kanoni S, Shrader P, Cavalcanti-Proenca C, Kumari M, Qi L, 39 
Timpson NJ, Gieger C, Zabena C, Rocheleau G, Ingelsson E, An P, O'Connell J, Luan J, Elliott A, 40 
McCarroll SA, Payne F, Roccasecca RM, Pattou F, Sethupathy P, Ardlie K, Ariyurek Y, Balkau B, 41 
Barter P, Beilby JP, Ben-Shlomo Y, Benediktsson R, Bennett AJ, Bergmann S, Bochud M, 42 
Boerwinkle E, Bonnefond A, Bonnycastle LL, Borch-Johnsen K, Bottcher Y, Brunner E, Bumpstead 43 
SJ, Charpentier G, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Cornelis M, Crawford G, 44 
Crisponi L, Day IN, de Geus EJ, Delplanque J, Dina C, Erdos MR, Fedson AC, Fischer-Rosinsky A, 45 
Forouhi NG, Fox CS, Frants R, Franzosi MG, Galan P, Goodarzi MO, Graessler J, Groves CJ, 46 
Grundy S, Gwilliam R, Gyllensten U, Hadjadj S, Hallmans G, Hammond N, Han X, Hartikainen AL, 47 
Hassanali N, Hayward C, Heath SC, Hercberg S, Herder C, Hicks AA, Hillman DR, Hingorani AD, 48 
Hofman A, Hui J, Hung J, Isomaa B, Johnson PR, Jorgensen T, Jula A, Kaakinen M, Kaprio J, 49 
Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, 50 
Le Bacquer O, Lecoeur C, Li Y, Lyssenko V, Mahley R, Mangino M, Manning AK, Martinez-Larrad 51 
MT, McAteer JB, McCulloch LJ, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, 52 
Morken MA, Mukherjee S, Naitza S, Narisu N, Neville MJ, Oostra BA, Orru M, Pakyz R, Palmer 53 
CN, Paolisso G, Pattaro C, Pearson D, Peden JF, Pedersen NL, Perola M, Pfeiffer AF, Pichler I, 54 
Polasek O, Posthuma D, Potter SC, Pouta A, Province MA, Psaty BM, Rathmann W, Rayner NW, 55 
 23 
Rice K, Ripatti S, Rivadeneira F, Roden M, Rolandsson O, Sandbaek A, Sandhu M, Sanna S, Sayer 1 
AA, Scheet P, Scott LJ, Seedorf U, Sharp SJ, Shields B, Sigurethsson G, Sijbrands EJ, Silveira A, 2 
Simpson L, Singleton A, Smith NL, Sovio U, Swift A, Syddall H, Syvanen AC, Tanaka T, Thorand 3 
B, Tichet J, Tonjes A, Tuomi T, Uitterlinden AG, van Dijk KW, van Hoek M, Varma D, Visvikis-4 
Siest S, Vitart V, Vogelzangs N, Waeber G, Wagner PJ, Walley A, Walters GB, Ward KL, Watkins 5 
H, Weedon MN, Wild SH, Willemsen G, Witteman JC, Yarnell JW, Zeggini E, Zelenika D, Zethelius 6 
B, Zhai G, Zhao JH, Zillikens MC, Borecki IB, Loos RJ, Meneton P, Magnusson PK, Nathan DM, 7 
Williams GH, Hattersley AT, Silander K, Salomaa V, Smith GD, Bornstein SR, Schwarz P, Spranger 8 
J, Karpe F, Shuldiner AR, Cooper C, Dedoussis GV, Serrano-Rios M, Morris AD, Lind L, Palmer LJ, 9 
Hu FB, Franks PW, Ebrahim S, Marmot M, Kao WH, Pankow JS, Sampson MJ, Kuusisto J, Laakso 10 
M, Hansen T, Pedersen O, Pramstaller PP, Wichmann HE, Illig T, Rudan I, Wright AF, Stumvoll M, 11 
Campbell H, Wilson JF, Bergman RN, Buchanan TA, Collins FS, Mohlke KL, Tuomilehto J, Valle 12 
TT, Altshuler D, Rotter JI, Siscovick DS, Penninx BW, Boomsma DI, Deloukas P, Spector TD, 13 
Frayling TM, Ferrucci L, Kong A, Thorsteinsdottir U, Stefansson K, van Duijn CM, Aulchenko YS, 14 
Cao A, Scuteri A, Schlessinger D, Uda M, Ruokonen A, Jarvelin MR, Waterworth DM, Vollenweider 15 
P, Peltonen L, Mooser V, Abecasis GR, Wareham NJ, Sladek R, Froguel P, Watanabe RM, Meigs JB, 16 
Groop L, Boehnke M, McCarthy MI, Florez JC, Barroso I (2010) New genetic loci implicated in 17 
fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42 (2):105-116. 18 
doi:ng.520 [pii] 19 
10.1038/ng.520 20 
147. Rees SD, Hydrie MZ, O'Hare JP, Kumar S, Shera AS, Basit A, Barnett AH, Kelly MA (2011) 21 
Effects of 16 genetic variants on fasting glucose and type 2 diabetes in South Asians: ADCY5 and 22 
GLIS3 variants may predispose to type 2 diabetes. PLoS One 6 (9):e24710. 23 
doi:10.1371/journal.pone.0024710 24 
148. Hodson DJ, Mitchell RK, Marselli L, Pullen TJ, Gimeno Brias S, Semplici F, Everett KL, 25 
Cooper DMF, Bugliani M, Marchetti P, Lavallard V, Bosco D, Piemonti L, Johnson PR, Hughes SJ, 26 
Li D, Li W-H, Shapiro AMJ, Rutter GA (2014) ADCY5 couples glucose to insulin secretion in human 27 
islets Diabetes In press 28 
149. Wagner R, Dudziak K, Herzberg-Schafer SA, Machicao F, Stefan N, Staiger H, Haring HU, 29 
Fritsche A (2011) Glucose-raising genetic variants in MADD and ADCY5 impair conversion of 30 
proinsulin to insulin. PLoS One 6 (8):e23639. doi:10.1371/journal.pone.0023639 31 
150. Mears D, Sheppard NF, Jr., Atwater I, Rojas E (1995) Magnitude and modulation of pancreatic 32 
beta-cell gap junction electrical conductance in situ. J Membr Biol 146 (2):163-176 33 
151. Lemaire K, Ravier MA, Schraenen A, Creemers JW, Van de Plas R, Granvik M, Van Lommel L, 34 
Waelkens E, Chimienti F, Rutter GA, Gilon P, in't Veld PA, Schuit FC (2009) Insulin crystallization 35 
depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in 36 
mice. Proc Natl Acad Sci U S A 106 (35):14872-14877. doi:10.1073/pnas.0906587106 37 
152. Nicolson TJ, Bellomo EA, Wijesekara N, Loder MK, Baldwin JM, Gyulkhandanyan AV, 38 
Koshkin V, Tarasov AI, Carzaniga R, Kronenberger K, Taneja TK, da Silva Xavier G, Libert S, 39 
Froguel P, Scharfmann R, Stetsyuk V, Ravassard P, Parker H, Gribble FM, Reimann F, Sladek R, 40 
Hughes SJ, Johnson PR, Masseboeuf M, Burcelin R, Baldwin SA, Liu M, Lara-Lemus R, Arvan P, 41 
Schuit FC, Wheeler MB, Chimienti F, Rutter GA (2009) Insulin storage and glucose homeostasis in 42 
mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. 43 
Diabetes 58 (9):2070-2083. doi:10.2337/db09-0551 44 
153. Wijesekara N, Dai FF, Hardy AB, Giglou PR, Bhattacharjee A, Koshkin V, Chimienti F, 45 
Gaisano HY, Rutter GA, Wheeler MB (2010) Beta cell-specific Znt8 deletion in mice causes marked 46 
defects in insulin processing, crystallisation and secretion. Diabetologia 53 (8):1656-1668. 47 
doi:10.1007/s00125-010-1733-9 48 
154. Rutter GA (2010) Think zinc: New roles for zinc in the control of insulin secretion. Islets 2 49 
(1):49-50. doi:10.4161/isl.2.1.10259 50 
155. Tamaki M, Fujitani Y, Hara A, Uchida T, Tamura Y, Takeno K, Kawaguchi M, Watanabe T, 51 
Ogihara T, Fukunaka A, Shimizu T, Mita T, Kanazawa A, Imaizumi MO, Abe T, Kiyonari H, Hojyo 52 
S, Fukada T, Kawauchi T, Nagamatsu S, Hirano T, Kawamori R, Watada H (2013) The diabetes-53 
susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance. J Clin Invest 123 (10):4513-54 
4524. doi:10.1172/JCI68807 55 
 24 
156. Flannick J, Thorleifsson G, Beer NL, Jacobs SB, Grarup N, Burtt NP, Mahajan A, Fuchsberger 1 
C, Atzmon G, Benediktsson R, Blangero J, Bowden DW, Brandslund I, Brosnan J, Burslem F, 2 
Chambers J, Cho YS, Christensen C, Douglas DA, Duggirala R, Dymek Z, Farjoun Y, Fennell T, 3 
Fontanillas P, Forsen T, Gabriel S, Glaser B, Gudbjartsson DF, Hanis C, Hansen T, Hreidarsson AB, 4 
Hveem K, Ingelsson E, Isomaa B, Johansson S, Jorgensen T, Jorgensen ME, Kathiresan S, Kong A, 5 
Kooner J, Kravic J, Laakso M, Lee JY, Lind L, Lindgren CM, Linneberg A, Masson G, Meitinger T, 6 
Mohlke KL, Molven A, Morris AP, Potluri S, Rauramaa R, Ribel-Madsen R, Richard AM, Rolph T, 7 
Salomaa V, Segre AV, Skarstrand H, Steinthorsdottir V, Stringham HM, Sulem P, Tai ES, Teo YY, 8 
Teslovich T, Thorsteinsdottir U, Trimmer JK, Tuomi T, Tuomilehto J, Vaziri-Sani F, Voight BF, 9 
Wilson JG, Boehnke M, McCarthy MI, Njolstad PR, Pedersen O, Groop L, Cox DR, Stefansson K, 10 
Altshuler D (2014) Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat 11 
Genet 46 (4):357-363. doi:10.1038/ng.2915 12 
157. Gerber PA, Bellomo EA, Hodson DJ, Meur G, Solomou A, Mitchell RK, Hollinshead M, 13 
Chimienti F, Bosco D, Hughes SJ, Johnson PR, Rutter GA (2014) Hypoxia lowers SLC30A8/ZnT8 14 
expression and free cytosolic Zn2+ in pancreatic beta cells. Diabetologia. doi:10.1007/s00125-014-15 
3266-0 16 
158. Sun Z, Zhang DQ, McMahon DG (2009) Zinc modulation of hemi-gap-junction channel currents 17 
in retinal horizontal cells. J Neurophysiol 101 (4):1774-1780. doi:90581.2008 [pii] 18 
10.1152/jn.90581.2008 19 
159. Lurtz MM, Louis CF (2007) Intracellular calcium regulation of connexin43. Am J Physiol Cell 20 
Physiol 293 (6):C1806-1813. doi:00630.2006 [pii] 21 
10.1152/ajpcell.00630.2006 22 
160. Bavamian S, Pontes H, Cancela J, Charollais A, Startchik S, Van de Ville D, Meda P (2012) The 23 
intercellular synchronization of Ca2+ oscillations evaluates Cx36-dependent coupling. PLoS One 7 24 
(7):e41535. doi:10.1371/journal.pone.0041535 25 
161. Amisten S, Salehi A, Rorsman P, Jones PM, Persaud SJ (2013) An atlas and functional analysis 26 
of G-protein coupled receptors in human islets of Langerhans. Pharmacol Ther 139 (3):359-391. 27 
doi:10.1016/j.pharmthera.2013.05.004 28 
162. Zhou K, Pearson ER (2013) Insights from genome-wide association studies of drug response. 29 
Annu Rev Pharmacol Toxicol 53:299-310. doi:10.1146/annurev-pharmtox-011112-140237 30 
163. Meda P, Michaels RL, Halban PA, Orci L, Sheridan JD (1983) In vivo modulation of gap 31 
junctions and dye coupling between B-cells of the intact pancreatic islet. Diabetes 32 (9):858-868 32 
164. Donnelly LA, Doney ASF, Hattersley AT, Morris AD, Pearson ER (2006) The effect of obesity 33 
on glycaemic response to metformin or sulphonylureas in Type 2 diabetes. Diabet Med 23 (2):128-34 
133. doi:DOI 10.1111/j.1464-5491.2005.01755.x 35 
165. Kim S, Putrino D, Ghosh S, Brown EN (2011) A Granger causality measure for point process 36 
models of ensemble neural spiking activity. PLoS Comput Biol 7 (3):e1001110. 37 
doi:10.1371/journal.pcbi.1001110 38 
 39 
  40 
 25 
Acknowledgements 1 
The writing of this review article was supported by a Diabetes UK R.D. Lawrence Research 2 
Fellowship (12/0004431) to D.J.H. and Wellcome Trust Senior Investigator (WT098424AIA), 3 
MRC Programme (MR/J0003042/1), Diabetes UK Project Grant (11/0004210) and Royal Society 4 
Wolfson Research Merit Awards to G.A.R. The work leading to this publication has received 5 
support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 6 
155005 (IMIDIA), resources of which are composed of financial contribution from the European 7 
Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind 8 
contribution (G.A.R.). Lastly, we thank Miss Maria Paiva Pessoa for assistance with the figures.   9 
 26 
FIGURE LEGENDS 1 
 2 
Figure 1: Imaging and mapping beta cell network topology. (Above) Functional multicellular 3 
Ca2+ imaging is used to monitor the large-scale organization of glucose-induced population 4 
dynamics (above, left). By subjecting the resulting traces (from ~ 50-100 individual cells per 5 
islet) to correlation analyses, cells with coordinated activity can be identified and a functional 6 
connectivity map plotted based upon position within the imaged field (x-y) (above, right). Scale-7 
free connection distributions are typified by a minority of cells that host the majority of 8 
connections (nodes), while maintaining streamlined information flow due to a short pathlength. 9 
Although robust in the face of random attack, they are prone to collapse following a targeted 10 
attack (below, left). By contrast, non-scale free networks (e.g. random or lattice) may not 11 
efficiently propagate signals due to a long pathlength, and random attacks significantly reduce 12 
capacity (below, right).  13 
 14 
Figure 2: Schematic showing single cell and population level beta cell signaling. At the 15 
molecular level, glucose is transported into the beta cell before undergoing glycolysis to increase 16 
the ratio of free cytosolic ATP:ADP. This closes KATP channels, leading to opening of VDCC, 17 
Ca2+ influx and Ca2+-dependent exocytosis. At the population level, beta cell dynamics are further 18 
dictated by signaling circuits involving paracrine, juxtacrine, autocrine, electrotonic (GJ), neural 19 
and ciliary communications.  20 
 21 
Figure 3: Potential mechanisms by which T2D-associated genes may alter beta cell 22 
connectivity. ZnT8 gene variants disrupt cytosolic Ca2+ and Zn2+ handling, and both of these ions 23 
are required for normal GJ activity. ADCY5 gene variants decrease glucose-stimulated cAMP 24 
rises, a second messenger shown to increase GJ communications between beta cells. By contrast, 25 
TCF7L2 gene variants may disrupt normal GJ function through effects upon glucose-stimulated 26 
Ca2+ increases, as well as GLP-1-stimulated cAMP generation. 27 
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